Morgan Bonds to Retrospective Studies
This is a "connection" page, showing publications Morgan Bonds has written about Retrospective Studies.
Connection Strength
0.279
-
Risk Factors Associated With Readmission After Pancreatectomy: A Single-Institution Retrospective Cohort Study. Am Surg. 2022 Jun; 88(6):1104-1110.
Score: 0.111
-
Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX. Ann Surg. 2025 May 01; 281(5):852-860.
Score: 0.036
-
Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study. Ann Surg Oncol. 2023 Mar; 30(3):1463-1473.
Score: 0.031
-
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment. JAMA Oncol. 2020 Nov 01; 6(11):1733-1740.
Score: 0.027
-
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study. Br J Surg. 2020 08; 107(9):1171-1182.
Score: 0.026
-
The paralyzing effect of insurance status on throughput of acute spinal cord patients. Am J Surg. 2019 06; 217(6):1060-1064.
Score: 0.024
-
Tobacco Smoking Associated With Increased Anastomotic Disruption Following Pancreaticoduodenectomy. J Surg Res. 2019 01; 233:199-206.
Score: 0.023